Samuel McKay Net Worth & Insider Trades

Samuel McKay - Director, Anika Therapeutics Inc

As of January 26, 2006

What is Samuel McKay's Net Worth?

The current estimated net worth of Anika Therapeutics Inc's Director, Samuel McKay, is estimated to be about $957.45K . Samuel McKay owns about 1,874 units of Anika Therapeutics Inc common stock. In the last 3 years at Anika Therapeutics Inc, Samuel McKay has sold an estimated value of $264.27K worth.

What is Samuel McKay's Past Insider Trading?

Samuel McKay's largest sale order was 29,000 units , worth over $264.27K on April 15, 2004. In total, Samuel McKay has made about 4 transactions over 3 years of their time at Anika Therapeutics Inc. Samuel McKay usually trades in April, with the busiest year in 2006, 2005, 2004 and 2003.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Samuel McKay's' Mailing Address?

  • Mailing address is City Place Ii 17th Fl 185 Asylum St Hartford CT 06103 CT

Anika Therapeutics Inc Executive Compensation

Name
Year
Salary
Bonus
Other Earnings Plans or Compensations
Option Awards
Other Compensation
Total
Cheryl R. Blanchard, Ph.D. 2020 $548,077 $458,510 $5,335,439 $3,659,450 $27,958 $10,029,434
Michael L. Levitz 2020 $173,077 $73,601 $799,971 $799,993 $11,318 $1,857,960
David Colleran 2020 $344,077 $143,931 $645,900 $553,445 $18,263 $1,705,616
Thomas Finnerty 2020 $353,505 $143,169 $626,367 - $20,746 $1,143,787
James Loerop 2020 $381,563 $171,703 $464,449 - $22,156 $1,039,871
Joseph G. Darling 2020 $80,752 - - - $208,001 $288,753
Sylvia Cheung 2020 $294,252 - $924,637 - $89,644 $1,308,534
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/898437/000117184321002976/def14a_042921.htm

What are Anika Therapeutics Inc's Past Insider Trades?

Anika Therapeutics Inc's most recent insider trade came on May 12, 2022 by David Colleran who bought 1,500 units worth $32.05K . In the last 18 years, insiders at Anika Therapeutics Inc have sold an estimated value of $66.56M and bought an estimated value of $5.82M worth of shares. Insider trading is most common in February, with the busiest year in 2006 and 2017. The most active traders at the company are Charles H Sherwood, CEO and Director,  Steve Wheeler, Director,  and Joseph L Bower, Director .

Anika Therapeutics, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1